Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Fuller

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Pharmacotherapy|October 4, 2003
From club drug to orphan drug: sodium oxybate (Xyrem) for the treatment of cataplexyDavid E Fuller, Carl S Hornfeldt
Pharmacotherapy|June 18, 2002
Sodium oxybate (GHB) for treatment of cataplexyLowell A Borgen, Harry N Cook, Carl S Hornfeldt, et al.
Drug Safety|April 6, 2004
The Xyrem risk management programDavid E Fuller, Carl S Hornfeldt, Judy S Kelloway, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Pharmacotherapy|October 4, 2003
From club drug to orphan drug: sodium oxybate (Xyrem) for the treatment of cataplexyDavid E Fuller, Carl S Hornfeldt
Pharmacotherapy|June 18, 2002
Sodium oxybate (GHB) for treatment of cataplexyLowell A Borgen, Harry N Cook, Carl S Hornfeldt, et al.
Drug Safety|April 6, 2004
The Xyrem risk management programDavid E Fuller, Carl S Hornfeldt, Judy S Kelloway, et al.
Pageof 1